Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis
Eric D. Shah, Jessica K. Salwen‐Deremer, Peter R. Gibson, Jane G. Muir, Shanti Eswaran, William D. Chey
Topics & Concepts
MedicineIrritable bowel syndromeMedical prescriptionRifaximinGuidelineDiarrheaWillingness to payCost–benefit analysisCost–utility analysisQuality of life (healthcare)Intensive care medicineCost effectivenessPsychiatryInternal medicineBiologyNursingMicrobiologyMicroeconomicsEcologyPathologyEconomicsPharmacologyAntibioticsRisk analysis (engineering)Gastrointestinal motility and disordersInflammatory Bowel DiseaseClinical Nutrition and Gastroenterology